Dr. Jonathan Conrad Romanyshyn, MD

Dr. Romanyshyn practices at Community Regional Medical Center in Fresno, California, part of Community Health System.

Dr. Romanyshyn's NPI, 1942450069, was assigned on September 25, 2008. Dr. Romanyshyn graduated from Yale School of Medicine in 2010. Dr. Romanyshyn's California license number on file is A120296.

Dr. Romanyshyn's primary practice is Community Regional Medical Center, at 2823 Fresno Street, Fresno, CA 93721 in Fresno County. The practice phone is (559) 459-6000.

Dr. Romanyshyn's primary practice is Community Regional Medical Center in Fresno, California, part of Community Health System. Dr. Romanyshyn is also affiliated with Clovis Community Medical Center. The medical group on file is Inspire Health Medical Group. Dmand AI also links Dr. Romanyshyn to 1 more home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Romanyshyn practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Romanyshyn's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Romanyshyn is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Romanyshyn's licenses on file in 2 states: California and Rhode Island.

Dmand AI lists colon removal, multiple traumatic injuries, non-surgical back problems and traumatic coma among the conditions Dr. Romanyshyn treats.

CMS data shows 840 Medicare services from Dr. Romanyshyn across 14 procedure codes in 2024, for 172 Medicare patients. Medicare paid $45,146 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 172 Medicare patients who saw Dr. Romanyshyn in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 3.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Romanyshyn's median patient age at 56, with 49% women.

In 2024, Dr. Romanyshyn wrote 30 Medicare Part D claims for 20 patients. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Romanyshyn for performance year 2024, reported as part of a group. Dr. Romanyshyn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 135 procedures of removal of tissue by Dr. Romanyshyn, more than 88% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Romanyshyn, published from 2010 to 2020. The most frequent topics are Oropharyngeal Neoplasms, Radiotherapy, Intensity-Modulated and Analysis of Variance. Dr. Romanyshyn has published most often in Int J Radiat Oncol Biol Phys. Dr. Romanyshyn's most frequent co-authors are Daphna Y. Gelblum, MD, Nancy Lee, MD and Jeremy S. Setton, MD.

CMS Open Payments shows 94 general payments to Dr. Romanyshyn from 19 drug and device companies from 2017 to 2025. Education make up the largest share, 49% of the total. Intuitive Surgical, Inc. paid the most, $11,873.

Dr. Romanyshyn graduated from Yale School of Medicine in 2010.

Dr. Romanyshyn is in network with 9 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.